Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6323625

CCCCCCC(C)CCCC.N

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.58
DNM1 Q05193 2/20 0.52
OPRM1 P35372 1/20 0.50
LMNA P02545 2/20 0.48
TSHR P16473 1/20 0.47
THRB P10828 1/20 0.47
SPHK1 Q9NYA1 1/20 0.46
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCI P41743 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCZ Q05513 1/20 0.44
PRKCD Q05655 1/20 0.44
PRKD1 Q15139 1/20 0.44
ADH1B P00325 1/20 0.43
ADH1C P00326 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL6315336 1.00 ACE2 (0.58) ACE2DNM1OPRM1LMNATSHR
Tridecane SCHEMBL7456037 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
SCHEMBL2306362 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
SCHEMBL1647280 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
SCHEMBL22986837 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
Ammonia Solution, Strong SCHEMBL25176706 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
SCHEMBL16800063 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
SCHEMBL2311296 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
Ammonia Solution, Strong SCHEMBL21518199 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR
SCHEMBL873562 0.97 ACE2 (0.60) ACE2DNM1OPRM1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560966-B1 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE AFTON CHEMICAL CORP (US) 2023-12-13 EP claimed
US-11760953-B2 Multifunctional branched polymers with improved low-temperature performance AFTON CHEMICAL CORPORATION (US) 2023-09-19 US claimed
CN-113528220-B Multifunctional branched polymers with improved low temperature properties 雅富顿化学公司 2022-12-16 CN claimed
US-20210340458-A1 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE AFTON CHEMICAL CORPORATION (US) 2021-11-04 US claimed
CN-113528220-A Multifunctional branched polymers with improved low temperature properties 雅富顿化学公司 2021-10-22 CN claimed
US-20190330554-A1 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE AFTON CHEMICAL CORPORATION (US) 2019-10-31 US claimed
EP-3560966-A2 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE Afton Chemical Corporation (US) 2019-10-30 EP claimed
EP-3560966-B1 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE AFTON CHEMICAL CORP (US) 2023-12-13 EP disclosed
US-11760953-B2 Multifunctional branched polymers with improved low-temperature performance AFTON CHEMICAL CORPORATION (US) 2023-09-19 US disclosed
CN-113528220-B Multifunctional branched polymers with improved low temperature properties 雅富顿化学公司 2022-12-16 CN disclosed
CN-110396450-B Multifunctional branched polymers with improved low temperature properties 雅富顿化学公司 2022-10-14 CN disclosed
US-20210340458-A1 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE AFTON CHEMICAL CORPORATION (US) 2021-11-04 US disclosed
CN-113528220-A Multifunctional branched polymers with improved low temperature properties 雅富顿化学公司 2021-10-22 CN disclosed
US-20190330554-A1 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE AFTON CHEMICAL CORPORATION (US) 2019-10-31 US disclosed
EP-3560966-A2 MULTIFUNCTIONAL BRANCHED POLYMERS WITH IMPROVED LOW-TEMPERATURE PERFORMANCE Afton Chemical Corporation (US) 2019-10-30 EP disclosed
US-20050058619-A1 Polyether-modified polymers as leather auxiliaries LANXESS DEUTSCHLAND GMBH (DE) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050058619-A1 Polyether-modified polymers as leather auxiliaries PUF60, B2M, CBR3 ACE2 1270/4885DNM1 4867/4885OPRM1 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.